Found: 8
Select item for more details and to access through your institution.
Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 94, doi. 10.1111/dom.13042
- By:
- Publication type:
- Article
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2020, v. 11, n. 6, p. 1525, doi. 10.1002/jcsm.12639
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338).
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 1, p. 141, doi. 10.1007/s40262-022-01189-0
- By:
- Publication type:
- Article
Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study.
- Published in:
- Journal of the American Geriatrics Society, 2017, v. 65, n. 9, p. 1988, doi. 10.1111/jgs.14927
- By:
- Publication type:
- Article
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 1, p. e2033457, doi. 10.1001/jamanetworkopen.2020.33457
- By:
- Publication type:
- Article
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2020836, doi. 10.1001/jamanetworkopen.2020.20836
- By:
- Publication type:
- Article
Clinical pharmacokinetics of intranasal sumatriptan.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes.
- Published in:
- Clinical Endocrinology, 2018, v. 88, n. 6, p. 908, doi. 10.1111/cen.13601
- By:
- Publication type:
- Article